PubRank

Alfons J M Balm

Author PubWeight™ 59.80‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Dysphagia and aspiration after chemoradiotherapy for head-and-neck cancer: which anatomic structures are affected and can they be spared by IMRT? Int J Radiat Oncol Biol Phys 2004 3.40
2 Intra-arterial versus intravenous chemoradiation for advanced head and neck cancer: Results of a randomized phase 3 trial. Cancer 2010 2.40
3 Increased risk of ischemic stroke after radiotherapy on the neck in patients younger than 60 years. J Clin Oncol 2002 1.79
4 Hearing loss due to concurrent daily low-dose cisplatin chemoradiation for locally advanced head and neck cancer. Radiother Oncol 2008 1.73
5 Comparing the hybrid fluorescent-radioactive tracer indocyanine green-99mTc-nanocolloid with 99mTc-nanocolloid for sentinel node identification: a validation study using lymphoscintigraphy and SPECT/CT. J Nucl Med 2012 1.53
6 Increased carotid wall thickening after radiotherapy on the neck. Eur J Cancer 2005 1.25
7 Feasibility of sentinel node biopsy in head and neck melanoma using a hybrid radioactive and fluorescent tracer. Ann Surg Oncol 2011 1.25
8 Pulmonary squamous cell carcinoma following head and neck squamous cell carcinoma: metastasis or second primary? Clin Cancer Res 2005 1.17
9 Concomitant radio- and fluorescence-guided sentinel lymph node biopsy in squamous cell carcinoma of the oral cavity using ICG-(99m)Tc-nanocolloid. Eur J Nucl Med Mol Imaging 2012 1.15
10 Postlaryngectomy voice rehabilitation: state of the art at the millennium. World J Surg 2003 1.11
11 First-year quality of life assessment of an intra-arterial (RADPLAT) versus intravenous chemoradiation phase III trial. Head Neck 2009 1.08
12 Assessment of lymphatic drainage patterns and implications for the extent of neck dissection in head and neck melanoma patients. J Surg Oncol 2011 1.07
13 Molecular markers predict outcome in squamous cell carcinoma of the head and neck after concomitant cisplatin-based chemoradiation. Int J Cancer 2009 1.04
14 Is photodynamic therapy a good alternative to surgery and radiotherapy in the treatment of head and neck cancer? Photodiagnosis Photodyn Ther 2009 1.01
15 Effects of oral administration of N-acetyl-L-cysteine: a multi-biomarker study in smokers. Cancer Epidemiol Biomarkers Prev 2002 1.00
16 Oropharyngeal squamous cell carcinoma: a unique disease on the rise? Oral Oncol 2010 0.99
17 Superficial parotidectomy via facelift incision. Ann Otol Rhinol Laryngol 2009 0.98
18 A portable gamma-camera for intraoperative detection of sentinel nodes in the head and neck region. J Nucl Med 2010 0.98
19 Pretreatment probability model for predicting outcome after intraarterial chemoradiation for advanced head and neck carcinoma. Cancer 2004 0.97
20 Multimodal Surgical Guidance during Sentinel Node Biopsy for Melanoma: Combined Gamma Tracing and Fluorescence Imaging of the Sentinel Node through Use of the Hybrid Tracer Indocyanine Green-(99m)Tc-Nanocolloid. Radiology 2014 0.95
21 A new problem-solving indwelling voice prosthesis, eliminating the need for frequent Candida- and "underpressure"-related replacements: Provox ActiValve. Acta Otolaryngol 2003 0.93
22 Prospective clinical phase II study of two new indwelling voice prostheses (Provox Vega 22.5 and 20 Fr) and a novel anterograde insertion device (Provox Smart Inserter). Laryngoscope 2010 0.93
23 Sensorineural hearing loss in patients with head and neck cancer after chemoradiotherapy and radiotherapy: a systematic review of the literature. Head Neck 2014 0.92
24 Effectiveness of salvage selective and modified radical neck dissection for regional pathologic lymphadenopathy after chemoradiation. Head Neck 2009 0.92
25 Poorly differentiated thyroid carcinoma presenting with gross extrathyroidal extension: 1986-2009 Memorial Sloan-Kettering Cancer Center experience. Thyroid 2013 0.92
26 Response measurement after intraarterial chemoradiation in advanced head and neck carcinoma: magnetic resonance imaging and evaluation under general anesthesia? Cancer 2006 0.92
27 HPV and high-risk gene expression profiles predict response to chemoradiotherapy in head and neck cancer, independent of clinical factors. Radiother Oncol 2010 0.91
28 Clinical phase I/feasibility study of the next generation indwelling Provox voice prosthesis (Provox Vega). Acta Otolaryngol 2010 0.90
29 Concurrent chemoradiation with daily low dose cisplatin for advanced stage head and neck carcinoma. Radiother Oncol 2007 0.90
30 Relationship between clinical factors and the incidence of toxicity after intra-arterial chemoradiation for head and neck cancer. Radiother Oncol 2006 0.90
31 Prognostic value of primary tumor volume after concurrent chemoradiation with daily low-dose cisplatin for advanced-stage head and neck carcinoma. Head Neck 2008 0.88
32 Prediction of treatment outcome by cisplatin-DNA adduct formation in patients with stage III/IV head and neck squamous cell carcinoma, treated by concurrent cisplatin-radiation (RADPLAT). Int J Cancer 2006 0.88
33 Dilemma of clinically node-negative head and neck melanoma: outcome of "watch and wait" policy, elective lymph node dissection, and sentinel node biopsy--a systematic review. Head Neck 2008 0.88
34 Imaging findings in craniofacial childhood rhabdomyosarcoma. Pediatr Radiol 2010 0.87
35 The AMORE protocol for advanced-stage and recurrent nonorbital rhabdomyosarcoma in the head-and-neck region of children: a radiation oncology view. Int J Radiat Oncol Biol Phys 2009 0.87
36 Validation of tissue array technology in head and neck squamous cell carcinoma. Head Neck 2003 0.87
37 Accuracy of fine-needle aspiration cytology of salivary gland lesions in the netherlands cancer institute. Head Neck 2004 0.86
38 Lymphatic drainage patterns from melanomas on the shoulder or upper trunk to cervical lymph nodes and implications for the extent of neck dissection. Ann Surg Oncol 2012 0.85
39 SPECT/CT for sentinel lymph node mapping in head and neck melanoma. Head Neck 2011 0.84
40 Five-year quality of life results of the randomized clinical phase III (RADPLAT) trial, comparing concomitant intra-arterial versus intravenous chemoradiotherapy in locally advanced head and neck cancer. Head Neck 2011 0.84
41 Cadaver study on the location of suboccipital lymph nodes: Guidance for suboccipital node dissection. Head Neck 2013 0.83
42 Head and neck squamous cell carcinoma in young patients. Oral Oncol 2013 0.83
43 Genetic abnormalities associated with chemoradiation resistance of head and neck squamous cell carcinoma. Clin Cancer Res 2007 0.83
44 Phase 1 study to identify tumour hypoxia in patients with head and neck cancer using technetium-99m BRU 59-21. Eur J Nucl Med Mol Imaging 2002 0.82
45 Oral and oropharyngeal squamous cell carcinoma in young patients: the Netherlands Cancer Institute experience. Head Neck 2012 0.82
46 Cine MRI of swallowing in patients with advanced oral or oropharyngeal carcinoma: a feasibility study. Eur Arch Otorhinolaryngol 2012 0.82
47 Intra-arterial chemotherapy for head and neck cancer: is there a verdict? Cancer 2010 0.81
48 Development and clinical assessment of a heat and moisture exchanger with a multi-magnet automatic tracheostoma valve (Provox FreeHands HME) for vocal and pulmonary rehabilitation after total laryngectomy. Acta Otolaryngol 2003 0.81
49 Ultrasound-guided aspiration cytology for the assessment of the clinically N0 neck: factors influencing its accuracy. Head Neck 2008 0.80
50 Introduction of lymphangiography and percutaneous embolization of the thoracic duct in a stepwise approach to the management of chylous fistulas. Head Neck 2007 0.80
51 Long-term hearing loss after chemoradiation in patients with head and neck cancer. Laryngoscope 2014 0.80
52 Cardiovascular and respiratory complications after major head and neck surgery. Head Neck 2006 0.80
53 Quality-of-life assessment after supradose selective intra-arterial cisplatin and concomitant radiation (RADPLAT) for inoperable stage IV head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 2002 0.79
54 Cochlea sparing effects of intensity modulated radiation therapy in head and neck cancers patients: a long-term follow-up study. J Otolaryngol Head Neck Surg 2014 0.78
55 AMORE protocol in pediatric head and neck rhabdomyosarcoma: descriptive analysis of failure patterns. Head Neck 2005 0.78
56 Regional control of melanoma neck node metastasis after selective neck dissection with or without adjuvant radiotherapy. Arch Otolaryngol Head Neck Surg 2009 0.78
57 Effectiveness of therapeutic (N1, N2) selective neck dissection (levels II to V) in patients with laryngeal and hypopharyngeal squamous cell carcinoma. Am J Surg 2004 0.78
58 Semi-automated primary tumor volume measurements by dynamic contrast-enhanced MRI in patients with head and neck cancer. Head Neck 2012 0.77
59 Survival after surgical resection of pulmonary metastases and second primary squamous cell lung carcinomas in head and neck cancer. Head Neck 2009 0.77
60 Can extranodal spread in head and neck cancer be detected on MR imaging. Oral Oncol 2013 0.77
61 Endoscopic management of Ewing's sarcoma of ethmoid sinus within the AMORE framework: a new paradigm. Int J Pediatr Otorhinolaryngol 2012 0.76
62 T stage as prognostic factor in irradiated localized squamous cell carcinoma of the nasal vestibule. Head Neck 2002 0.76
63 Preoperative imaging and surgical margins in maxillectomy patients. Head Neck 2012 0.76
64 Comment on Heuveling et al.: Nanocolloidal albumin-IRDye 800CW: a near-infrared fluorescent tracer with optimal retention in the sentinel lymph node. Eur J Nucl Med Mol Imaging 2012 0.75
65 Volume criteria for the treatment of head and neck cancer: Are they evidence based? Head Neck 2014 0.75
66 [Pleomorphic adenoma of the parotid gland, rules for resection]. Ned Tijdschr Geneeskd 2012 0.75
67 [The carotid body paraganglioma: a rare swelling of the neck]. Ned Tijdschr Geneeskd 2015 0.75
68 Increased risk of breast cancer development after diagnosis of salivary gland tumour. Eur J Cancer 2005 0.75
69 10th International Symposium on Head And Neck Skin Cancer. Expert Rev Anticancer Ther 2011 0.75
70 Radiology quiz case 2. Laryngeal plasmacytoma in a patient with known multiple myeloma (MM). Arch Otolaryngol Head Neck Surg 2005 0.75